已收盘 07-25 16:00:00 美东时间
+0.070
+1.54%
Odysight.ai Inc. has delivered a vision-based monitoring system for Israel's Heron TP UAV, developed for the Ministry of Defense. The system uses advanced algorithms and miniature sensors to enhance engine health monitoring and operational safety, particularly for Pratt & Whitney's PT6A-67 engine. It serves both defense and civil applications, leveraging AI for predictive maintenance. CEO Yehu Ofer highlighted the system's ability to monitor hard...
07-24 12:30
Odysight.AI has signed a commercial agreement with a multinational technology group to deploy proof-of-concepts in defense, mining, agriculture, and heavy vehicles. Successful trials in extreme conditions validate their predictive maintenance technology, leading to expanded deployments across multiple industries. Both parties aim to enhance safety, efficiency, and sustainability through real-time monitoring and cost reduction.
07-22 12:30
Odysight.AI Inc., a developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), has been added to the Russell Microcap® Index. This inclusion follows the 2025 Russell indexes reconstitution, which captures the 4,000 largest U.S. stocks based on market capitalization. Einav Brenner, CFO, commented that this recognition enhances the company's visibility with institutional investors and reinforces confidence in its...
07-01 12:30
Odysight.AI Inc. (NASDAQ:ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the receipt of an initial order for its Predictive Health
06-16 20:34
Odysight.AI Inc. has received an initial order for its AI-powered Predictive Health Monitoring (PHM) system, designed to monitor belts and cables in cranes and elevators across key industrial sectors. The system, developed for a European industry leader, uses high-resolution cameras and machine learning to detect early faults and predict failures in real-time. A pilot program will begin with several transportation system OEMs, followed by a globa...
06-16 12:30
Odysight ai (NASDAQ:ODYS) reported quarterly losses of $(0.29) per share. This is a 3.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported $2.06 million in sales this
05-15 20:24
Bristol Myers' Camzyos missed goals in a Phase 3 nHCM trial, showing no significant benefits over placebo but raised no new safety concerns.
04-16 03:53
Earnings Call Insights: Clearside Biomedical (CLSD) Q4 2024 Management View CEO George Lasezkay highlighted the company's progress in advancing its suprachoroidal delivery platform, noting over 15,000...
03-28 08:31
Odysight.ai press release (NASDAQ:ODYS): FY2024 net loss of $11.8M, compared to $9.4M in 2023. Revenues of approximately $4M (+31% Y/Y). Backlog reached ~$15M, an increase of over 450% compared to Dec...
03-27 19:21